Overall ACLX gets a fundamental rating of 3 out of 10. We evaluated ACLX against 525 industry peers in the Biotechnology industry. ACLX has a great financial health rating, but its profitability evaluates not so good. ACLX does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year ACLX has reported negative net income.
In the past year ACLX has reported a negative cash flow from operations.
In the past 5 years ACLX always reported negative net income.
In the past 5 years ACLX reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -33.23%, ACLX is in the better half of the industry, outperforming 64.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of -49.43%, ACLX is in the better half of the industry, outperforming 66.86% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-33.23%
ROE	-49.43%
ROIC	N/A

ROA(3y)-27.93%

ROA(5y)-37.97%

ROE(3y)-43.4%

ROE(5y)-50.36%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ACLX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ACLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACLX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ACLX has been increased compared to 5 years ago.
The debt/assets ratio for ACLX has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 9.12 indicates that ACLX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.12, ACLX belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
There is no outstanding debt for ACLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	9.12

ROIC/WACCN/A

WACC8.86%

2.3 Liquidity

A Current Ratio of 4.00 indicates that ACLX has no problem at all paying its short term obligations.
The Current ratio of ACLX (4.00) is comparable to the rest of the industry.
A Quick Ratio of 4.00 indicates that ACLX has no problem at all paying its short term obligations.
ACLX has a Quick ratio (4.00) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	4
Quick Ratio	4

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ACLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -453.52%.
ACLX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -76.96%.

EPS 1Y (TTM)-453.52%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-106.25%

Revenue 1Y (TTM)-76.96%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-80.99%

3.2 Future

ACLX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.78% yearly.
ACLX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 43.24% yearly.

EPS Next Y-106.91%

EPS Next 2Y-33.01%

EPS Next 3Y-9.66%

EPS Next 5Y29.78%

Revenue Next Year-73.06%

Revenue Next 2Y5.01%

Revenue Next 3Y25.74%

Revenue Next 5Y43.24%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ACLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACLX. No positive earnings are expected for the next year.